 <h1>Darifenacin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of darifenacin include:</b> constipation and xerostomia. <b>Other side effects include:</b> dyspepsia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to darifenacin: oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, darifenacin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking darifenacin:</p><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>difficult, burning, or painful urination</li>
<li>frequent urge to urinate</li>
<li>lower back or side pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Decrease in the frequency of urination</li>
<li>decrease in the urine volume</li>
<li>difficulty in passing urine</li>
<li>dribbling or painful urination</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking darifenacin:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Changes in vision</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of darifenacin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>difficulty having a bowel movement (stool)</li>
<li>dry mouth</li>
<li>heartburn</li>
<li>indigestion</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>dizziness</li>
<li>dry eyes</li>
<li>lack or loss of strength</li>
<li>nausea</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Accidental injury</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>changes in vision</li>
<li>chills</li>
<li>congestion</li>
<li>cough producing mucus</li>
<li>difficulty with breathing</li>
<li>difficulty with moving</li>
<li>dry skin</li>
<li>dryness or soreness of the throat</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>hoarseness</li>
<li>itching of the vagina or genital area</li>
<li>itching skin</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>muscle stiffness</li>
<li>nervousness</li>
<li>pain during sexual intercourse</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>pounding in the ears</li>
<li>rash</li>
<li>runny nose</li>
<li>shortness of breath or troubled breathing</li>
<li>slow or fast heartbeat </li>
<li>sneezing</li>
<li>stuffy nose</li>
<li>tender, swollen glands in the neck</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>trouble with swallowing</li>
<li>unusual weight gain or loss</li>
<li>voice changes</li>
<li>vomiting</li>
<li>wheezing</li>
</ul><p>
<!-- end oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to darifenacin: oral tablet extended release</i></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Palpitations, syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 35%), constipation (up to 21%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, nausea, dyspepsia, diarrhea </p>
<p><b>Uncommon</b> (0.1% to 1%): Vomiting, flatulence, mouth ulceration, hyperhidrosis</p>
<p><b>Frequency not reported</b>: Angioedema<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Dry skin, pruritus, rash</p>
<p><b>Postmarketing reports</b>: Erythema multiforme, interstitial granuloma annulare<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasal dryness, bronchitis, respiratory tract infection, pharyngitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspnea, cough, rhinitis<sup>[Ref]</sup></p><h3>General</h3><p>Most adverse events were mild or moderate and mostly occurred during the first 2 weeks of treatment.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection, urinary retention, urinary tract disorder, bladder pain, erectile dysfunction, vaginitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Weight gain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Aspartate aminotransferase increased, alanine aminotransferase increased<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Generalized hypersensitivity reactions including angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Dizziness, dysgeusia, somnolence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Dry eye</p>
<p><b>Uncommon</b> (0.1% to 1%): Visual disturbance, blurred vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Edema, peripheral edema, face edema, asthenia, aspartate aminotransferase increased, alanine aminotransferase increased, accidental injury, pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia, abnormal thinking</p>
<p><b>Postmarketing reports</b>: Depressed mood, altered mood, hallucination<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Darifenacin ER (darifenacin)." Cipla USA Inc., Miami, FL. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about darifenacin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>24 Reviews</li>
<li>Drug class: urinary antispasmodics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Darifenacin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Enablex</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Overactive Bladder</li>
<li>Urinary Incontinence</li>
<li>Urinary Frequency</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to darifenacin: oral tablet extended release</i></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Palpitations, syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 35%), constipation (up to 21%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, dyspepsia, diarrhea </p><p><b>Uncommon</b> (0.1% to 1%): Vomiting, flatulence, mouth ulceration, hyperhidrosis</p><p><b>Frequency not reported</b>: Angioedema<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Dry skin, pruritus, rash</p><p><b>Postmarketing reports</b>: Erythema multiforme, interstitial granuloma annulare<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Nasal dryness, bronchitis, respiratory tract infection, pharyngitis</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea, cough, rhinitis<sup>[Ref]</sup></p><h3>General</h3><p>Most adverse events were mild or moderate and mostly occurred during the first 2 weeks of treatment.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection, urinary retention, urinary tract disorder, bladder pain, erectile dysfunction, vaginitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Weight gain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Aspartate aminotransferase increased, alanine aminotransferase increased<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Generalized hypersensitivity reactions including angioedema<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache</p><p><b>Uncommon</b> (0.1% to 1%): Dizziness, dysgeusia, somnolence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Dry eye</p><p><b>Uncommon</b> (0.1% to 1%): Visual disturbance, blurred vision<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Edema, peripheral edema, face edema, asthenia, aspartate aminotransferase increased, alanine aminotransferase increased, accidental injury, pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia, abnormal thinking</p><p><b>Postmarketing reports</b>: Depressed mood, altered mood, hallucination<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Darifenacin ER (darifenacin)." Cipla USA Inc., Miami, FL. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about darifenacin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>24 Reviews</li>
<li>Drug class: urinary antispasmodics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Darifenacin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Overactive Bladder</li>
<li>Urinary Incontinence</li>
<li>Urinary Frequency</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>